Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01879592 · ClinicalTrials.gov registry record
Molecular Phenotyping of Asthma in Sickle Cell Disease
A clinical trial of Asthma and Sickle Cell Disease, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- 99
- Enrollment target
- 3
- Study locations
NCT01879592 is a study of Asthma and Sickle Cell Disease that has completed, run by Nemours Children's Clinic. The registered enrollment target is 99 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (94% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT01879592, a study of Asthma and Sickle Cell Disease, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
- 3
- Study locations
Study Summary
Asthma and sickle cell disease each are serious medical problems. People with asthma have difficulty breathing, wheeze (a whistling noise when breathing), cough, produce sputum or phlegm, and have inflammation (swelling, irritation, redness) and narrowing of the bronchial tubes. When a person has both asthma and sickle cell disease together, more serious medical problems can occur such as having acute chest syndrome and pain episodes more often. It is sometimes hard to diagnose asthma in a person with sickle cell disease because sickle cell disease can also cause lung problems. The purpose of this study is to see if the investigators can better understand asthma when it occurs in a person who has sickle cell disease. The investigators will do this by taking a blood, urine, and saliva sample. The blood and urine samples will be analyzed for chemicals and DNA (genes). Certain genes can cause patients to have sickle cell disease or asthma. The investigators will use the saliva sample for future studies to compare the results from the blood testing with saliva. The investigator's long-term goal is to make sure people who have asthma and sickle cell disease are getting the best asthma treatments. The investigator's hypothesis is that the analysis of the blood, urine and saliva using a method called, metabolomics, may identify a unique asthma signature in children with sickle cell disease which may lead to targeted treatments.
Conditions Studied
Study Locations (3)
Florida
- Nemours Children's Clinic - Jacksonville
- Nemours Children's Clinic - Orlando
Delaware
- Nemours Children's Clinic - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2011-06 |
| Est. Completion | 2016-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01879592
The ClinicalTrials.gov registry entry for NCT01879592 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (94% lower). The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT01879592 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Florida, Delaware.
Frequently Asked Questions
What is clinical trial NCT01879592 about?
NCT01879592 is a clinical study titled "Molecular Phenotyping of Asthma in Sickle Cell Disease". Asthma and sickle cell disease each are serious medical problems. People with asthma have difficulty breathing, wheeze (a whistling noise when breathing), cough, produce sputum or phlegm, and have inflammation (swelling, irritation, redness) and narrowing of the bronchial tubes. When a person has b...
What is the current status of trial NCT01879592?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2011-06. Estimated completion is 2016-02-28.
What conditions does trial NCT01879592 study?
This clinical trial studies the following conditions: Asthma, Sickle Cell Disease.
Who is sponsoring clinical trial NCT01879592?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01879592 being conducted?
This trial has 3 study locations across Delaware, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.